Current standards and future directions for prostate cancer radiation therapy - Abstract

Definitive radiation therapy is a well-recognized curative treatment option for localized prostate cancer.

A suitable technique, dose, target volume and the option of a combination with androgen deprivation therapy need to be considered. An optimal standard external beam radiotherapy currently includes intensity-modulated and image-guided radiotherapy techniques with total doses of ≥76-78 Gy in conventional fractionation. Protons or carbon ions are alternatives available only in specific centers. Data from several randomized studies increasingly support the rationale for hypofractionated radiotherapy. A simultaneous integrated boost with dose escalation focused on a computed tomography/PET- or MRI/magnetic resonance spectroscopy-detected malignant lesion is one option to increase tumor control, with potentially no additional toxicity. The application of a spacer is a promising concept for optimal protection of the rectal wall.

Written by:
Pinkawa M, Schoth F, Böhmer D, Hatiboglu G, Sharabi A, Song D, Eble MJ.   Are you the author?
Department of Radiation Oncology, RWTH Aachen University, Pauwelsstrasse 30, 52057 Aachen, Germany.

Reference: Expert Rev Anticancer Ther. 2013 Jan;13(1):75-88.
doi: 10.1586/era.12.156

PubMed Abstract
PMID: 23259429

Go "Beyond the Abstract" - Read an Article Written by the Authors for Prostate Cancer Section